Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.41 |
| ▸ | CMKLR1 | Q99788 | 4/20 | 0.40 |
| ▸ | BTK | Q06187 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1132086 | 0.88 | HRH3 (0.41) | HRH3CMKLR1BTKCYP2D6FDFT1 | |
| SCHEMBL12860214 | 0.86 | CMKLR1 (0.42) | HRH3CMKLR1CYP2D6FDFT1ALOX5 | |
| SCHEMBL1132052 | 0.78 | PTGS1 (0.41) | HRH3CMKLR1BTKRAB9A | |
| SCHEMBL12860095 | 0.78 | CNR1 (0.46) | CMKLR1BTKALOX5 | |
| SCHEMBL1131332 | 0.78 | PTGS1 (0.41) | HRH3CMKLR1BTKRAB9A | |
| SCHEMBL1131969 | 0.78 | CMKLR1 (0.41) | HRH3CMKLR1BTKRAB9A | |
| SCHEMBL1131971 | 0.78 | CMKLR1 (0.41) | HRH3CMKLR1BTKRAB9A | |
| SCHEMBL1132018 | 0.77 | FABP3 (0.46) | HRH3CMKLR1BTKCYP2D6FDFT1 | |
| SCHEMBL1131853 | 0.77 | BTK (0.42) | HRH3CMKLR1BTKNPC1RAB9A | |
| SCHEMBL1132025 | 0.76 | PTPN1 (0.43) | HRH3CMKLR1BTKNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1663105-B1 | CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS | BRISTOL MYERS SQUIBB CO (US) | 2011-02-16 | — | — | EP | disclosed |